Medical Litigation Management Houston, TX - 77027

Medical Litigation Management is categorized under Management Services in Houston, TX and active since 2009.

Medical Litigation Management was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Management Services business, which does work in the B2B market, and is classified as a Management Services, under code number 5416905 by the NAICS.

If you are seeking more information, feel free to contact Constance B Sunday at the company’s single location by writing to 3919 Essex Lane Apartment 130, Houston, Texas TX 77027 or by phoning (713) 963-0407. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medical Litigation Management
Contact Person: Constance B Sunday
Address: 3919 Essex Lane Apartment 130, Houston, Texas 77027
Phone Number: (713) 963-0407
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Management Services
SIC Code: 8741
NAICS Code: 5416905
Share This Business:

Medical Litigation Management was started in 2009 to provide professional Management Services under the SIC code 8741 and NAICS code 5416905. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Constance B Sunday for inquiries that concern Medical Litigation Management by calling the company number (713) 963-0407, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Litigation Management can be found at the coordinates 29.7396,-95.442373 as well as the street address 3919 Essex Lane Apartment 130 in Houston, Texas 77027.

For its online presence, you may visit Medical Litigation Management’s website at and engage with its social media outlets through on Twitter and on Facebook.